13035-13-7

Upstream product

• 13035-12-6 3,4,6-tri-O-acetyl-1,2-dideoxy-D-glucopyranose 
• 2873-29-2 D-glucal triacetate 
• 100-52-7 benzaldehyde 
• 3971-47-9 (3S,4R)-dihydroxy-(2R)-(hydroxymethyl)tetrahydropyran 
• 1125-88-8 benzaldehyde dimethyl acetal 

Downstream Products

• 131926-00-6 tert-Butyl-dimethyl-((4aR,8R,8aR)-2-phenyl-hexahydro-pyrano[3,2-d][1,3]dioxin-8-yloxy)-silane 
• 116558-21-5 1,5-anhydro-4,6-O-benzylidene-2-deoxy-D-erythro-hex-3-ulose 
• 181266-85-3 {(2S,3S)-3-[(R)-1-((2R,3S,4S)-3,4-Bis-benzyloxy-tetrahydro-pyran-2-yl)-ethyl]-oxiranyl}-methanol 
• 181266-63-7 (2S,3S,4S)-4-((2R,3S,4S)-3,4-Bis-benzyloxy-tetrahydro-pyran-2-yl)-2-methyl-pentane-1,3-diol 
• 181489-33-8 (2R,3R,4S)-4-((2R,3S,4S)-3,4-Bis-benzyloxy-tetrahydro-pyran-2-yl)-2-methyl-pentane-1,3-diol 
• 181267-20-9 (2R,4S,5S,6R,9S,10S,11S)-2,5,10-Tris-benzyloxy-11-((2R,3S,4S)-3,4-bis-benzyloxy-tetrahydro-pyran-2-yl)-4,9-dimethyl-dodecan-6-ol 
• 181267-15-2 (2R,4S,5S,9S,10S,11S)-2,5,10-Tris-benzyloxy-11-((2R,3S,4S)-3,4-bis-benzyloxy-tetrahydro-pyran-2-yl)-4,9-dimethyl-dodecan-6-one 
• 181267-10-7 (E)-(2R,4S,5S,9S,10S,11S)-2,5,10-Tris-benzyloxy-11-((2R,3S,4S)-3,4-bis-benzyloxy-tetrahydro-pyran-2-yl)-4,9-dimethyl-dodec-7-en-6-one 
• 181266-50-2 (E)-(S)-4-((2R,3S,4S)-3,4-Bis-benzyloxy-tetrahydro-pyran-2-yl)-pent-2-enoic acid ethyl ester 
• 181266-20-6 (E)-3-((2R,3S,4S)-3,4-Bis-benzyloxy-tetrahydro-pyran-2-yl)-acrylic acid methyl ester 
• 181266-43-3 (2R,3S)-3-((2R,3S,4S)-3,4-Bis-benzyloxy-tetrahydro-pyran-2-yl)-butane-1,2-diol 
• 181266-57-9 (E)-(S)-4-((2R,3S,4S)-3,4-Bis-benzyloxy-tetrahydro-pyran-2-yl)-pent-2-en-1-ol 

Relevant academic research and scientific papers

GLYCOSAMINOGLYCAN (GAG) MIMETICS

The invention relates to compounds that are designed to mimic the structure of GAGs; methods for the preparation of the compounds; compositions comprising the compounds; and use of the compounds and compositions thereof for the anti-angiogenic, anti-metas

Biomimetic cyclisation of prebrevetoxin polyepoxide models

(E)-1,3-Dihydroxyhex-4-ene and (E)-1,3-dihydroxy-4-methylhex-4-ene undergo epoxidation with peracetic acid and in situ cyclisation to give a mixture of tetrahydro-furans and -pyrans, whereas comparable compounds lacking the allylic hydroxyl group give pre

Die Struktur von Maitotoxin - I: Konfiguration der C1-C14-Seitenkette

Keywords: Konfigurationsbestimmung; Konformation; Maitotoxin; Naturstoffe; NMR-Spektroskopie

Asymmetric Michael Addition with Amino Alcohol Catalysts Derived from D-Glucose

An enantioselective Michael addition of thiophenols to 2-cyclohexen-1-one was performed with catalysts of γ-amino alcohols that were synthesized from D-glucose.A linear relationship between the optical yield of this Michael addition and the specific rotat